{"id":"https://openalex.org/W2980072097","doi":"https://doi.org/10.1182/blood.v106.11.2671.2671","title":"The Impact of Relative Dose Intensity on Response and Survival in a Series of 180 Newly Diagnosed Patients with Hodgkin\u2019s Lymphoma.","display_name":"The Impact of Relative Dose Intensity on Response and Survival in a Series of 180 Newly Diagnosed Patients with Hodgkin\u2019s Lymphoma.","publication_year":2005,"publication_date":"2005-11-16","ids":{"openalex":"https://openalex.org/W2980072097","doi":"https://doi.org/10.1182/blood.v106.11.2671.2671","mag":"2980072097"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v106.11.2671.2671","doi":"https://doi.org/10.1182/blood.v106.11.2671.2671","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v106.11.2671.2671","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016024062","display_name":"Filippo Russo","orcid":"https://orcid.org/0000-0001-8128-9878","observed_orcids":["https://orcid.org/0000-0001-8128-9878"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Filippo Russo","raw_affiliation_strings":["(Intr. by Bruno Rotoli)","Onco-Hematology Unit, National Cancer Institute, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"(Intr. by Bruno Rotoli)","institution_ids":[]},{"raw_affiliation_string":"Onco-Hematology Unit, National Cancer Institute, Naples, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023571222","display_name":"Gino Svanera","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gino Svanera","raw_affiliation_strings":["(Intr. by Bruno Rotoli)","Onco-Hematology Unit, National Cancer Institute, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"(Intr. by Bruno Rotoli)","institution_ids":[]},{"raw_affiliation_string":"Onco-Hematology Unit, National Cancer Institute, Naples, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006135944","display_name":"Paola Della Cioppa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paola Della Cioppa","raw_affiliation_strings":["(Intr. by Bruno Rotoli)","Onco-Hematology Unit, National Cancer Institute, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"(Intr. by Bruno Rotoli)","institution_ids":[]},{"raw_affiliation_string":"Onco-Hematology Unit, National Cancer Institute, Naples, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087147482","display_name":"Gaetano Corazzelli","orcid":"https://orcid.org/0000-0002-9548-4807","observed_orcids":["https://orcid.org/0000-0002-9548-4807"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gaetano Corazzelli","raw_affiliation_strings":["(Intr. by Bruno Rotoli)","Onco-Hematology Unit, National Cancer Institute, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"(Intr. by Bruno Rotoli)","institution_ids":[]},{"raw_affiliation_string":"Onco-Hematology Unit, National Cancer Institute, Naples, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077919557","display_name":"Ferdinando Frigeri","orcid":"https://orcid.org/0000-0002-9818-3073","observed_orcids":["https://orcid.org/0000-0002-9818-3073"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ferdinando Frigeri","raw_affiliation_strings":["(Intr. by Bruno Rotoli)","Onco-Hematology Unit, National Cancer Institute, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"(Intr. by Bruno Rotoli)","institution_ids":[]},{"raw_affiliation_string":"Onco-Hematology Unit, National Cancer Institute, Naples, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103735331","display_name":"Gaetana Capobianco","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gaetana Capobianco","raw_affiliation_strings":["(Intr. by Bruno Rotoli)","Onco-Hematology Unit, National Cancer Institute, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"(Intr. by Bruno Rotoli)","institution_ids":[]},{"raw_affiliation_string":"Onco-Hematology Unit, National Cancer Institute, Naples, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089152448","display_name":"Secondo Lastoria","orcid":"https://orcid.org/0000-0002-6649-9903","observed_orcids":["https://orcid.org/0000-0002-6649-9903"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Secondo LaStoria","raw_affiliation_strings":["(Intr. by Bruno Rotoli)","Nuclear Medicine, National Cancer Institute, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"(Intr. by Bruno Rotoli)","institution_ids":[]},{"raw_affiliation_string":"Nuclear Medicine, National Cancer Institute, Naples, Italy","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033029228","display_name":"Antonio Pinto","orcid":"https://orcid.org/0000-0002-9425-9026","observed_orcids":["https://orcid.org/0000-0002-9425-9026"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antonio Pinto","raw_affiliation_strings":["(Intr. by Bruno Rotoli)","Onco-Hematology Unit, National Cancer Institute, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"(Intr. by Bruno Rotoli)","institution_ids":[]},{"raw_affiliation_string":"Onco-Hematology Unit, National Cancer Institute, Naples, Italy","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.45403657,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"106","issue":"11","first_page":"2671","last_page":"2671"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hodgkin-lymphoma","display_name":"Hodgkin's disease","score":0.9380000233650208},{"id":"https://openalex.org/keywords/relative-dose-intensity","display_name":"relative dose intensity","score":0.9620000123977661},{"id":"https://openalex.org/keywords/abvd","display_name":"ABVD chemotherapy","score":0.7820000052452087},{"id":"https://openalex.org/keywords/dose-dense-chemotherapy","display_name":"dose-dense chemotherapy","score":0.8709999918937683},{"id":"https://openalex.org/keywords/granulocyte-colony-stimulating-factor","display_name":"granulocyte colony-stimulating factor","score":0.8240000009536743},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.7329999804496765},{"id":"https://openalex.org/keywords/event-free-survival","display_name":"event-free survival","score":0.9919999837875366},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9990000128746033},{"id":"https://openalex.org/keywords/radiotherapy","display_name":"radiotherapy","score":0.4399999976158142},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7080000042915344},{"id":"https://openalex.org/keywords/prognostic-score","display_name":"prognostic score","score":0.43299999833106995},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.3709999918937683}],"concepts":[{"id":"https://openalex.org/C2776305933","wikidata":"https://www.wikidata.org/wiki/Q287631","display_name":"ABVD","level":5,"score":0.9738086462020874},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8140292167663574},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5183687806129456},{"id":"https://openalex.org/C2780964509","wikidata":"https://www.wikidata.org/wiki/Q416975","display_name":"Dacarbazine","level":3,"score":0.4753910303115845},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.41635164618492126},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3958663046360016},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.34716135263442993},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3224034905433655},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.2597697079181671},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.08668294548988342}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v106.11.2671.2671","doi":"https://doi.org/10.1182/blood.v106.11.2671.2671","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v106.11.2671.2671","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2980176815","https://openalex.org/W1968882633","https://openalex.org/W2979357266","https://openalex.org/W1506066026","https://openalex.org/W2110203708","https://openalex.org/W4285794310","https://openalex.org/W2050942542","https://openalex.org/W4205827921","https://openalex.org/W2979884264","https://openalex.org/W2125199453"],"abstract_inverted_index":{"Abstract":[0],"To":[1],"improve":[2],"ABVD":[3,16,46],"results":[4,129,351],"we":[5,39,222],"first":[6,168],"developed":[7],"a":[8,35,41,134,396],"protocol":[9,296],"which":[10],"adds":[11],"G-CSF":[12,83,370],"to":[13,21,62,75,88,150,164,231,243,360,372,447],"the":[14,56,68,165,179,192,207,224,232,290,318,321,340,343,361,367,383],"standard":[15,36,389],"treatment.":[17],"From":[18,101],"March":[19],"1997":[20],"May":[22],"2004":[23],"69":[24],"patients":[25,105,124,139,146,284,332],"with":[26,30,34,108,126,133,174,185,198,212,285],"HL":[27,123,145],"were":[28,92,106,130,158,281,333,345],"treated":[29,107,125],"ABVD+G-CSF":[31],"and":[32,44,67,90,96,190,203,227,246,252,266,279,293,305,339,375,394,402,444],"22":[33],"ABVD.":[37,127],"Recently":[38],"designed":[40],"new":[42,54,291],"dose-dense":[43,292,374],"dose-intensity":[45,112,294],"scheme":[47],"(escABVD-21)":[48],"for":[49,116,258,262,268],"advanced":[50,415],"HL;":[51],"in":[52,160,283,300],"this":[53,109],"schedule":[55,344],"adriamycin":[57,338],"was":[58,71,84,114,348],"escalated":[59],"from":[60,73,86,148],"25":[61],"35":[63],"mg/m2":[64],"(cycles":[65],"1,2,3,4)":[66],"inter-cycle":[69],"period":[70],"shortened":[72],"28":[74],"21":[76],"days":[77],"(for":[78],"all":[79,330],"6":[80],"cycles);":[81],"primary":[82],"administered":[85],"d3":[87],"d8":[89],"drugs":[91],"delivered":[93],"at":[94,317],"d10":[95],"d21":[97],"of":[98,118,137,153,215,235,249,276,302,320,337,342,363,386,388,409,456],"every":[99],"cycle.":[100],"June":[102],"2004,":[103],"19":[104],"protocol.":[110],"Relative":[111],"(RDI)":[113],"calculated":[115],"any":[117],"these":[119],"110":[120],"newly":[121],"diagnosed":[122],"The":[128,167,272,335],"also":[131],"compared":[132],"historical":[135],"group":[136,169,209],"70":[138],"who":[140],"had":[141],"undergone":[142],"hybrid":[143],"MOPP/ABVD.":[144],"received":[147],"4":[149,161,233,253,448],"8":[151],"cycles":[152],"CT":[154],"+/\u2212":[155],"IF-RT.":[156],"Patients":[157],"divided":[159],"groups":[162,250],"according":[163,230,242,446],"RDI.":[166,236],"included":[170,210],"20":[171,479,500],"(11%)":[172,480,501],"pts":[173,184,197,211,309,410],"RDI":[175,186,199,213,286,355,364,392,449,451],"less":[176],"than":[177,217],"0.80;":[178],"2nd":[180,322],"group,":[181,194],"64":[182,485],"(36%)":[183,486],"values":[187,200,214],"between":[188,201],"0.80":[189],"0.95,":[191],"3rd":[193],"74":[195],"(42%)":[196,495],"0.96":[202],"1.10":[204],"and,":[205,324],"finally,":[206],"4th":[208],"more":[216],"1.10.":[218],"In":[219,288],"Tab":[220],"2":[221],"report":[223],"CR,":[225,277],"EFS":[226,240,263,278,465],"OS":[228,269,280],"rates":[229,248,275],"levels":[234,450],"Figures":[237],"1":[238],"shows":[239],"curve":[241],"Kaplan-Meyer.":[244],"Response":[245,443],"survival":[247,403],"1,2,3":[251],"were:":[254],"50%vs91%vs97%":[255],"vs":[256],"100%,":[257],"CR":[259,459],"(p<0.0001);":[260],"20%vs78%vs92%vs100%":[261],"(p<":[264,270],"0.0001);":[265],"25%vs91%vs99%vs100%":[267],"0.0001).":[271],"best":[273],"progression":[274],"seen":[282],">1.10.":[287],"particular,":[289],"escABVD-21":[295,381],"seems":[297],"very":[298],"promising":[299],"terms":[301],"complete":[303,400],"response":[304,401],"toxicity":[306,347,387],"profile:":[307],"19/19":[308],"(100%)":[310],"obtained":[311],"an":[312],"early":[313],"CR;":[314],"(PET":[315],"negative":[316],"end":[319],"cycle),":[323],"as":[325,380],"on":[326,399],"8th":[327],"August":[328],"2005,":[329],"these19":[331],"disease-free.":[334],"dose-escalation":[336],"dose-density":[341],"well-tolerated;":[346],"mild.":[349],"These":[350],"show":[352],"that":[353],"subptimal":[354],"may":[356],"compromise":[357],"outcomes":[358],"proportionally":[359],"level":[362,452],"reduction.":[365],"On":[366],"contrary,":[368],"Primary":[369],"permits":[371],"deliver":[373],"dose":[376],"intense":[377],"schedules":[378],"such":[379],"maintaining":[382],"same":[384],"profile":[385],"ABVD,":[390],"higher":[391],"levels,":[393],"consequently,":[395],"significant":[397],"impact":[398],"rates.":[404],"tab1":[405],"Presentation":[406],"features":[407],"n.":[408],"male":[411],"sex":[412],"age>45":[413],"yrs":[414],"stage":[416],"E":[417],"sites>1":[418],"bulky":[419],"B":[420],"symptoms":[421],"IPI":[422],"score":[423],"\u2265":[424],"3":[425],"180":[426],"92":[427],"43":[428],"148":[429],"23":[430],"80":[431],"83":[432],"56":[433],"%":[434],"51%":[435],"24%":[436],"82%":[437],"13%":[438],"44%":[439],"46%":[440],"31%":[441],"tab.2":[442],"Survival":[445],"(range":[453],"0.5\u20131.5)":[454],"N.":[455],"pts.":[457],"(%)":[458],"rate":[460,466,470],"Fisher\u2019s":[461],"Exact":[462],"test":[463],"(2-sided)":[464],"log-rank":[467,471],"statistic":[468,472],"0S":[469],"overall":[473],"180(100%)":[474],"90%":[475],"80%":[476],"88%":[477],"<0.80":[478],"50%":[481],"20%":[482],"25%":[483],"0.80\u20130.95":[484],"91%":[487,491],"28.391":[488],"78%":[489],"74.99":[490],"96.76":[492],"0.96\u20131.10":[493],"76":[494],"97%":[496],"92%":[497],"99%":[498],">1.10":[499],"100%":[502,503,504],"significance":[505],"<0.0001":[506,507,508],"Figure":[509,510]},"counts_by_year":[{"year":2022,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2019-10-18T00:00:00"}